193 related articles for article (PubMed ID: 14624203)
1. Atypical (olanzapine) plus conventional (fluphenazine) neuroleptic treatment associated with the neuroleptic malignant syndrome.
Tofler IT; Ahmed B
J Clin Psychopharmacol; 2003 Dec; 23(6):672-4. PubMed ID: 14624203
[No Abstract] [Full Text] [Related]
2. Series of seizures as a sign of development of recurrent malignant neuroleptic syndrome - a case report.
Supe S; Matijević V; Kondić L; Alvir D
Psychiatr Danub; 2006 Jun; 18(1-2):97-101. PubMed ID: 16804507
[TBL] [Abstract][Full Text] [Related]
3. Potentiating effect of fluphenazine decanoate and risperidone on development of neuroleptic malignant syndrome.
Liu PY; Wu PC; Chen CY; Chen YC
Gen Hosp Psychiatry; 2011; 33(1):84.e5-7. PubMed ID: 21353143
[TBL] [Abstract][Full Text] [Related]
4. Late-onset neuroleptic malignant syndrome in a patient using olanzapine.
Kunz M; Gomes FA; Tramontina JF; Kapczinski F
J Clin Psychopharmacol; 2007 Jun; 27(3):303-4. PubMed ID: 17502780
[No Abstract] [Full Text] [Related]
5. Neuroleptic malignant syndrome with the addition of aripiprazole to olanzapine.
Marshall PB; Mellman TA; Nguyen SX
Am J Psychiatry; 2008 Nov; 165(11):1488-9. PubMed ID: 18981078
[No Abstract] [Full Text] [Related]
6. [Neuroleptic malignant syndrome--a case report].
Lanczik M; Fritze J
Psychiatr Prax; 1992 May; 19(3):84-6. PubMed ID: 1353269
[TBL] [Abstract][Full Text] [Related]
7. Atypical neuroleptic malignant syndrome caused by olanzapine.
Nielsen J; Bruhn AM
Acta Psychiatr Scand; 2005 Sep; 112(3):238-40; discussion 240. PubMed ID: 16095481
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic malignant syndrome during low dosed neuroleptic medication in first-episode psychosis: a case report.
Gönner F; Baumgartner R; Schüpbach D; Merlo MC
Psychopharmacology (Berl); 1999 Jun; 144(4):416-8. PubMed ID: 10435416
[TBL] [Abstract][Full Text] [Related]
9. Atypical neuroleptic malignant syndrome in H1N1 pneumonia.
Crosby D; Peterson J; Carroll BT
Ann Clin Psychiatry; 2013 Feb; 25(1):69-70. PubMed ID: 23376873
[No Abstract] [Full Text] [Related]
10. Olanzapine induced neuroleptic malignant syndrome.
Patra BN; Khandelwal SK; Sood M
Indian J Pharmacol; 2013; 45(1):98-9. PubMed ID: 23543750
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine-induced atypical neuroleptic malignant syndrome in an adolescent man with anorexia nervosa.
Ayyıldız H; Turan Ş; Gülcü D; Poyraz CA; Pehlivanoğlu E; Çullu F; Arıkan MK
Eat Weight Disord; 2016 Jun; 21(2):309-11. PubMed ID: 26607823
[No Abstract] [Full Text] [Related]
12. [Association of atypical neuroleptics with anticonvulsants and malignant syndrome. Report of 2 cases].
Nabih FO; Benali A; Adali I; Manoudi F; Asri F
Pan Afr Med J; 2014; 18():220. PubMed ID: 25422695
[TBL] [Abstract][Full Text] [Related]
13. Atypicality in presentation of neuroleptic malignant syndrome caused by olanzapine.
Mishra B; Mishra B; Sahoo S; Arora M; Khess CR
Indian J Med Sci; 2007 Oct; 61(10):570-3. PubMed ID: 17932448
[TBL] [Abstract][Full Text] [Related]
14. NMS after clozapine initiation.
Skarpathiotakis M; Westreich N
J Am Acad Child Adolesc Psychiatry; 2005 Nov; 44(11):1101-2. PubMed ID: 16239854
[No Abstract] [Full Text] [Related]
15. Neuroleptic Malignant Syndrome Induced by Olanzapine in a Patient with Huntington's Disease.
Moreno JL; Palau Fayos JM; Díaz de Santiago A; García de Yébenes J
J Huntingtons Dis; 2012; 1(1):31-2. PubMed ID: 25063189
[No Abstract] [Full Text] [Related]
16. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
Järventausta K; Leinonen E
Acta Psychiatr Scand; 2000 Sep; 102(3):231-3. PubMed ID: 11008860
[TBL] [Abstract][Full Text] [Related]
17. [Electroconvulsion therapy for neuroleptic malignant syndrome].
Buggenhout S; Vandenberghe J; Sienaert P
Tijdschr Psychiatr; 2014; 56(9):612-5. PubMed ID: 25222100
[TBL] [Abstract][Full Text] [Related]
18. Olanzapine usage associated with neuroleptic malignant syndrome.
Philibert RA; Adam LA; Frank FM; Carney-Doebbeling C
Psychosomatics; 2001; 42(6):528-9. PubMed ID: 11815691
[No Abstract] [Full Text] [Related]
19. Neuroleptic malignant syndrome and low-dose olanzapine.
Suh H; Bronson B; Martin R
Am J Psychiatry; 2003 Apr; 160(4):796. PubMed ID: 12668376
[No Abstract] [Full Text] [Related]
20. Persistent amnesia as a sequel of olanzapine-induced neuroleptic malignant syndrome.
Mendhekar DN; Duggal HS
J Neuropsychiatry Clin Neurosci; 2006; 18(4):552-3. PubMed ID: 17135384
[No Abstract] [Full Text] [Related]
[Next] [New Search]
